XORTX Therapeutics Inc. (XRTX) NASDAQ
0.40
-0.049(-10.89%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.40
-0.049(-10.89%)
Currency In USD
| Market Cap | 3.65M |
| Enterprise Value | 2.52M |
| P/E Ratio | -0.85 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.78 |
| Return On Equity | -1.11 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -156,528 |
| EBITDA | -4.39M |
| Net Income | -3.71M |
| Diluted EPS | -0.78 |
| Total Cash | 1.18M |
| Total Cash/Share | 0.18 |
| Total Debt | 51,069 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.61 |
| Book Value Per Share | 0.44 |
| 52-Week Change | -60.3 |
| 52-Week High | 1.41 |
| 52-Week Low | 0.37 |
| Moving Average 50 Days | 0.49 |
| Moving Average 200 Days | 0.7 |
| Average Volume | 146,413 |
| Shares Outstanding | 3.79M |
| % Held by Institutions | 0.65 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | November 14, 2023 |